Cited by 77Retinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeOcular Infections and Treatments

Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration

Robman, Luba, Mahdi, Olaimatu, McCarty, Catherine, Dimitrov, Peter, Tikellis, Gabriella, McNeil, John, Byrne, Gerald, Taylor, Hugh +1 more·2005·American Journal of Epidemiology

Abstract

Recent studies have found an association between exposure to Chlamydia pneumoniae infection and risk of age-related macular degeneration (AMD). To assess a potential risk of AMD progression posed by exposure to C. pneumoniae, the authors reexamined Australian residents in 2001-2002 who were aged 51-89 years with early AMD at baseline (1992-1995). Examination included macular photography and an enzyme-linked immunosorbent assay to determine antibody titers to the elementary bodies from C. pneumoniae AR39. AMD progression was assessed quantitatively, using both coarse and fine progression steps following an international classification for AMD grading, and also qualitatively, by side-by-side comparison of baseline and follow-up macular photographs. Serologic data were available for 246 of 254 (97%) subjects. AMD progression was associated with a higher antibody titer. After adjustment for age, smoking, family history of AMD, history of cardiovascular diseases, and source study, the subjects in the upper tertiles of antibody titers were 2.1 (95% confidence interval: 0.92, 4.69), 2.6 (95% confidence interval: 1.24, 5.41), and 3.0 (95% confidence interval: 1.46, 6.37) times more at risk of progression than those in the lowest tertile, using three definitions of progression, respectively. The fact that seroreactivity to C. pneumoniae was independently associated with the risk of AMD progression suggests that C. pneumoniae infection may be an additional risk factor for AMD progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/aje/kwi130

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AMD patients have increased serum anti-C. pneumoniae antibodies, and these antibodies are linked to increased risk of AMD progression.

    “AMD patients have been found to possess increased serum anti-C. pneumoniae antibodies, and these antibodies have been linked to increased risk of AMD progression (Robman et al., 2005).”

    From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Robman et al., 2005

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Klein R, Klein B, Cruickshanks KJ. The prevalence of age- related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 1999;18:371-89.
  2. Klein R. Epidemiology. In: Berger JW, Fine SL, Maguire MG, eds. Age-related macular degeneration. St Louis, MO: Mosby, Inc, 1999:31-55.
  3. Shor A, Phillips JI. Chlamydia pneumoniae and atheroscle- rosis. JAMA 1999;282:2071-3.
  4. Taylor HR, Tikellis G, Robman LD, et al. Vitamin E sup- plementation and macular degeneration: randomised control- led trial. BMJ 2002;325:11-16.

Cited by

Sorted by citations

Authors
Robman, L., Mahdi, O., McCarty, C., Dimitrov, P., Tikellis, G., McNeil, J., Byrne, G., Taylor, H., & Guymer, R.
Affiliations
  • The University of Melbourne (AU)
  • University of Tennessee Health Science Center (US)
  • Marshfield Clinic (US)
  • The Alfred Hospital (AU)
Corresponding author
Robman, Luba
Venue
American Journal of Epidemiology
Published
2005-06-01
Volume
161
Issue
11
Pages
1013-1019
ISSN
  • 0002-9262 (ISSN-L)
  • 1476-6256
OpenAlex
W2134310989
Cited by
77
References
43
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 2 · 2019: 1 · 2018: 2 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 7 · 2012: 7
FWCI
8.23
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • Medical Research Council
  • National Health and Medical Research Council
  • National Institute of Allergy and Infectious Diseases (R01AI042790)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
Chlamydia pneumoniae, age-related macular degeneration, AMD progression, elementary bodies, infection risk factors
MeSH terms
Aged, Aged, 80 and over, Aging, Antibodies, Bacterial, Chlamydiaceae Infections, Enzyme-Linked Immunosorbent Assay, Female, Humans, Macular Degeneration, Male, Middle Aged, Risk Factors, Chlamydophila pneumoniae, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review